Sign In
Buy CRBP
$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
Cannabis Central: How Well Do The Two New TSX Cannabis Indexes Track The Industry's Stock Performance?
08:50pm, Tuesday, 07'th Apr 2020
As a result of the growing interest in the marijuana industry the S&P/TSX recently launched two indices, the S&P/TSX Cannabis Index and the S&P/MX International Cannabis Index to track the performance
Oppenheimer Sticks to Their Buy Rating for Soleno Therapeutics (SLNO)
03:26am, Tuesday, 07'th Apr 2020
Oppenheimer analyst Leland Gershell maintained a Buy rating on Soleno Therapeutics (SLNO) yesterday and set a price target of $11.00. The company's shares
Oppenheimer Sticks to Their Buy Rating for Soleno Therapeutics (SLNO)
03:26am, Tuesday, 07'th Apr 2020
Oppenheimer analyst
Leland Gershell
maintained a
Buy
rating on Soleno Therapeutics (
SLNO
–
Research Report
) yesterday and set a price target of
$11.00
. The company’s shares closed last Monday a
Oppenheimer Sticks to Its Buy Rating for Urogen Pharma (URGN)
03:10am, Monday, 06'th Apr 2020
Oppenheimer analyst Leland Gershell maintained a Buy rating on Urogen Pharma (URGN) yesterday and set a price target of $45.00. The company's shares
Oppenheimer Sticks to Its Buy Rating for Urogen Pharma (URGN)
03:10am, Monday, 06'th Apr 2020
Oppenheimer analyst Leland Gershell maintained a Buy rating on Urogen Pharma (URGN – Research Report) yesterday and set a price
Acceleron Pharma (XLRN) Receives a Buy from Oppenheimer
02:13am, Monday, 06'th Apr 2020
Oppenheimer analyst Leland Gershell maintained a Buy rating on Acceleron Pharma (XLRN) yesterday and set a price target of $112.00. The company's shares
Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Price Down 2.3%
08:52am, Saturday, 04'th Apr 2020
Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) fell 2.3% on Thursday . The company traded as low as $4.79 and last traded at $4.68, 35,144 shares changed hands during trading. A decline of 97% from
Implied Volatility Surging for Corbus (CRBP) Stock Options
12:58pm, Thursday, 02'nd Apr 2020
Investors need to pay close attention to Corbus (CRBP) stock based on the movements in the options market lately.
Implied Volatility Surging for Corbus (CRBP) Stock Options
12:58pm, Thursday, 02'nd Apr 2020
Investors need to pay close attention to Corbus (CRBP) stock based on the movements in the options market lately.
Oppenheimer Thinks Acasti Pharma's Stock is Going to Recover
10:09am, Thursday, 02'nd Apr 2020
In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on Acasti Pharma (ACST), with a price target of $7.00. The company's
Oppenheimer Thinks Acasti Pharma’s Stock is Going to Recover
10:09am, Thursday, 02'nd Apr 2020
In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on Acasti Pharma (ACST – Research Report),
Analysts' Top Healthcare Picks: Hologic (HOLX), Ascendis Pharma (ASND)
09:44am, Thursday, 02'nd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hologic (HOLX) and Ascendis Pharma (ASND) with bullish
Analysts’ Top Healthcare Picks: Hologic (HOLX), Ascendis Pharma (ASND)
09:44am, Thursday, 02'nd Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hologic (HOLX
Cannabis Central: Carnage Continued On Wednesday (-6.2%) With Only 3 Stocks Advancing
04:06am, Thursday, 02'nd Apr 2020
Sorry, your request could not be completed.
We
will try to fix your problem as soon as possible.
Thank you for your patience.
— The TalkMarkets Team
Back to Home page
Analysts Have Conflicting Sentiments on These Healthcare Companies: Orchard Therapeutics (ORTX) and Epizyme (EPZM)
10:22am, Wednesday, 01'st Apr 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Orchard Therapeutics (ORTX) and Epizyme (EPZM). Orchard
